萩勝彦 (Katsuhiko Hagi) - マイポータル

基本情報

所属: 住友ファーマ株式会社メディカルアフェアーズ部オフィサー

ORCID iD: https://orcid.org/0000-0003-1389-1474
J-GLOBAL ID: 202401011218678871
researchmap会員ID: R000070713

論文

Long‐term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52‐week postmarketing clinical study (<scp>TWINKLE</scp>)

Tetsuya Babazono, Takeshi Osonoi, Hideki Okamoto, Yukiko Onishi, Shinya Nakamoto, Masayuki Kashima, Daiji Kawanami, Eitaro Nakashima, Kei Watabe, Noriko Nunami …

Journal of Diabetes Investigation 2025年8月4日
Diagnosis and symptom assessment in telepsychiatry vs. face‐to‐face settings: A systematic review and meta‐analysis

Mayu Fujikawa, Katsuhiko Hagi, Shotaro Kinoshita, Akihiro Takamiya, Mari Iizuka, Shota Furukawa, Yoko Eguchi, Shunya Kurokawa, Ryo Takemura, Taishiro Kishimoto

Psychiatry and Clinical Neurosciences 2025年6月25日
Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post-hoc analysis of imeglimin clinical trial data.

Jumpei Ito, Katsuhiko Hagi, Kenji Kochi, Kohjiro Ueki, Hirotaka Watada, Kohei Kaku

Journal of diabetes investigation 16(4) 629-638 2025年4月
Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data‐driven cluster analysis: A post‐hoc analysis of imeglimin clinical trial data

Katsuhiko Hagi, Kenji Kochi, Hirotaka Watada, Kohei Kaku, Kohjiro Ueki

Diabetes, Obesity and Metabolism 2024年9月
Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus.

Katsuhiko Hagi, Kenji Kochi, Hirotaka Watada, Kohei Kaku, Kohjiro Ueki

Journal of diabetes investigation 2024年5月25日
Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.

Katsuhiko Hagi, Masahiro Nitta, Hirotaka Watada, Kohei Kaku, Kohjiro Ueki

Journal of diabetes investigation 14(11) 1246-1261 2023年11月
Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post-hoc analysis of two randomized, placebo-controlled trials.

Katsuhiko Hagi, Kenji Kochi, Hirotaka Watada, Kohei Kaku, Kohjiro Ueki

Journal of diabetes investigation 14(9) 1101-1109 2023年9月
Telepsychiatry versus face-to-face treatment: systematic review and meta-analysis of randomised controlled trials.

Katsuhiko Hagi, Shunya Kurokawa, Akihiro Takamiya, Mayu Fujikawa, Shotaro Kinoshita, Mari Iizuka, Shota Furukawa, Yoko Eguchi, Taishiro Kishimoto

The British journal of psychiatry : the journal of mental science 223(3) 407-414 2023年9月
Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis.

Taishiro Kishimoto, Katsuhiko Hagi, Shunya Kurokawa, John M Kane, Christoph U Correll

Psychological medicine 53(9) 4064-4082 2023年7月
Systematic Review and Network Meta-analysis: Efficacy and Safety of Second-Generation Antipsychotics in Youths With Bipolar Depression.

Melissa P DelBello, Aditi Kadakia, Vincent Heller, Rajpal Singh, Katsuhiko Hagi, Tadashi Nosaka, Antony Loebel

Journal of the American Academy of Child and Adolescent Psychiatry 61(2) 243-254 2022年2月
Corrigendum to "Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study". [Journal of Affective Disorders 281 (2021) 160-167].

Jun Ishigooka, Tadafumi Kato, Mari Miyajima, Kei Watabe, Takahiro Masuda, Katsuhiko Hagi, Teruhiko Higuchi

Journal of affective disorders 297 687-687 2022年1月15日
Corrigendum to "Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study". [Journal of Affective Disorders 281 (2021) 160-167].

Jun Ishigooka, Tadafumi Kato, Mari Miyajima, Kei Watabe, Takahiro Masuda, Katsuhiko Hagi, Teruhiko Higuchi

Journal of affective disorders 292 789-789 2021年9月1日
Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study.

Teruhiko Higuchi, Tadafumi Kato, Mari Miyajima, Kei Watabe, Takahiro Masuda, Katsuhiko Hagi, Jun Ishigooka

International journal of bipolar disorders 9(1) 25-25 2021年8月2日
Long-acting antipsychotics: is what we know really so? - Authors' reply.

Taishiro Kishimoto, Katsuhiko Hagi, Shunya Kurokawa, John M Kane, Christoph U Correll

The lancet. Psychiatry 8(8) 651-652 2021年8月
Long-acting injectable versus oral antipsychotics for schizophrenia - Authors' reply.

Taishiro Kishimoto, Katsuhiko Hagi, Shunya Kurokawa, John M Kane, Christoph U Correll

The lancet. Psychiatry 8(7) 567-567 2021年7月
Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.

Aditi Kadakia, Carole Dembek, Vincent Heller, Rajpal Singh, Jennifer Uyei, Katsuhiko Hagi, Tadashi Nosaka, Antony Loebel

BMC psychiatry 21(1) 249-249 2021年5月11日
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia: A Systematic Review and Meta-analysis.

Katsuhiko Hagi, Tadashi Nosaka, Dwight Dickinson, Jean Pierre Lindenmayer, Jimmy Lee, Joseph Friedman, Laurent Boyer, Mei Han, Nur Amirah Abdul-Rashid, Christoph U Correll

JAMA psychiatry 78(5) 510-518 2021年5月1日
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.

Taishiro Kishimoto, Katsuhiko Hagi, Shunya Kurokawa, John M Kane, Christoph U Correll

The lancet. Psychiatry 8(5) 387-404 2021年5月
Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials.

Itaru Miura, Tadashi Nosaka, Hirooki Yabe, Katsuhiko Hagi

The international journal of neuropsychopharmacology 24(3) 200-215 2021年3月17日
Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study.

Jun Ishigooka, Tadafumi Kato, Mari Miyajima, Kei Watabe, Takahiro Masuda, Katsuhiko Hagi, Teruhiko Higuchi

Journal of affective disorders 281 160-167 2021年2月15日

もっとみる